Impact Capital Partners LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 807 shares of the biotechnology company's stock, valued at approximately $480,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $120,553,000. Proficio Capital Partners LLC purchased a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $78,414,000. Westfield Capital Management Co. LP lifted its stake in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock valued at $86,354,000 after purchasing an additional 111,405 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Stock Down 2.7 %
Shares of Axon Enterprise stock traded down $14.83 on Tuesday, reaching $539.99. The company's stock had a trading volume of 558,270 shares, compared to its average volume of 857,660. The company has a market capitalization of $41.38 billion, a price-to-earnings ratio of 139.53, a P/E/G ratio of 5.17 and a beta of 1.12. The firm's fifty day simple moving average is $593.10 and its two-hundred day simple moving average is $538.04. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Insiders Place Their Bets
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares of the company's stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company's stock.
Analyst Ratings Changes
AXON has been the subject of a number of research analyst reports. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective for the company. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.
Read Our Latest Report on AXON
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
